tocophersolan has been researched along with amprenavir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bridgers, A; Coffin, M; Long, S; Polli, J; Roy, A; Vickers, A; Winnike, R; Yu, L | 1 |
| Annaert, P; Augustijns, P; Brouwers, J; Mols, R | 1 |
2 other study(ies) available for tocophersolan and amprenavir
| Article | Year |
|---|---|
Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.
Topics: Algorithms; Animals; Biological Availability; Caco-2 Cells; Calcium Channel Blockers; Carbamates; Cell Membrane Permeability; Chromatography, High Pressure Liquid; Dogs; Furans; HIV Protease Inhibitors; Humans; Permeability; Polyethylene Glycols; Solubility; Stimulation, Chemical; Sulfonamides; Verapamil; Vitamin E | 1999 |
Validation of a differential in situ perfusion method with mesenteric blood sampling in rats for intestinal drug interaction profiling.
Topics: Adrenergic beta-Antagonists; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbamates; Drug Interactions; Furans; Intestinal Absorption; Ketoconazole; Male; Perfusion; Polyethylene Glycols; Rats; Rats, Wistar; Splanchnic Circulation; Sulfonamides; Verapamil; Vitamin E | 2010 |